Search Results 651-660 of 16974 for pharmacogenetics
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Bevacizumab blocks the ability of tumors to grow new blood vessels and ...
This population will be queried for biologic use prior to age 18. The study population for the remainder of the study will be all CD and UC patients in ICN who ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
The purpose of this study is to evaluate molecular markers which might be a predictor of pancreatic cancer or precancer by analyzing the secretions (fluid) ...
Magnetic Resonance: Stephen J. · Melanoma Research: Svetomir N. · Membrane Trafficking in Disease: Mark A. · Memory Disorders: Neill R. · Meningeal Lymphatics and ...
The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...
Statins can save lives, are they being used? · Answers to common questions about whether vaccines are safe, effective and necessary featured image · Science ...
The purpose of this study is to describe the association between Prospera dd-cfDNA measures and other diagnostic tests used to detect heart allograft rejection ...
The Mayo Clinic Breast Cancer SPORE supports translational research projects on genetic mutations, Z-endoxifen and p95HER2 in HER2+ breast cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.